Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 13Other hematologic neoplasm 6Breast 6Head & Neck 5Other 4Lymphoid 4Genitourinary 4Thoracic 3Plasma cell 3Other neoplasm 3Tumor-Agnostic 2Myeloid 2Dermatologic 2CNS 2Gynecologic 1Classical hematology 1

Conditions

Lung Neoplasms 2Pleural Effusion, Malignant 1Neoplasm Metastasis 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 1145Cisplatin 874Pemetrexed 832pembrolizumab 604Paclitaxel 597Docetaxel 535Gemcitabine 424Radiotherapy 374Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 294durvalumab 254Drug Therapy 233osimertinib 217atezolizumab 207Radiosurgery 188Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 123Magnetic Resonance Spectroscopy 120Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Morphine × Thoracic × Clear all
NCT07002788 2025-06-04

Comparison Paravertebral and Serratus Anterior Plane Block in Video-assisted Thoracoscopic Surgery.

Hacettepe University

Phase NA Active not recruiting
122 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02040662 2017-06-12

Comparison of Efficacy of Paravertebral and Epidural Analgesia After Videothoracoscopic Lung Lobectomy

Pulmonary Hospital Zakopane

Phase 2 Completed
120 enrolled
Thoracic

Lung Neoplasms

NCT00644319 2009-07-08

Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion

National Cancer Institute (NCI)

Phase 2 Unknown
320 enrolled
Thoracic

Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡